Indian IP Bill Would Give Drug Inventor, Institution Shares Of Patent Profits

Pharmaceutical scientists and others are expected to benefit as well as the institutions they work for under a bill under review by the Indian government. A draft of the intellectual property measure proposes a system similar to that of the United States, which allows public institutions to patent inventions and enter into commercial ventures to market the work. The proposal, which India's Cabinet is to decide whether to introduce in Parliament, would have the inventor of the patentable product to receive 30 percent of market revenue, with 10 percent allocated to the institution where the work was produced. (Click here for more